Rathbone Brothers Form 8.3 - Dechra Pharmaceuticals Plc
17 January 2024 - 12:02AM
UK Regulatory
TIDMRAT TIDMDPH
8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Rathbones Group
Plc
-------------------------------------------------------------------- ---------------
(b) Owner or controller of interests and short positions
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient.
For a trust, the trustee(s), settlor and beneficiaries
must be named.
-------------------------------------------------------------------- ---------------
(c) Name of offeror/offeree in relation to whose relevant Dechra
securities this form relates: Pharmaceuticals
Use a separate form for each offeror/offeree PLC
-------------------------------------------------------------------- ---------------
(d) If an exempt fund manager connected with an offeror/offeree,
state this and specify identity of offeror/offeree:
-------------------------------------------------------------------- ---------------
(e) Date position held/dealing undertaken: 15/01/2024
For an opening position disclosure, state the latest
practicable date prior to the disclosure
-------------------------------------------------------------------- ---------------
(f) In addition to the company in 1(c) above, is the No
discloser making disclosures in respect of any other
party to the offer?
If it is a cash offer or possible cash offer, state
"N/A"
-------------------------------------------------------------------- ---------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security: 1p Ord
------------------------------------------------------ -----------------------------
Short
Interests positions
---------------- -----------
Number % Number %
------------------------------------------------------ --------- ----- ------ ---
(1) Relevant securities owned and/or controlled: 1,154,220 1.01%
------------------------------------------------------ --------- ----- ------ ---
(2) Cash-settled derivatives:
------------------------------------------------------ --------- ----- ------ ---
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell:
------------------------------------------------------ --------- ----- ------ ---
TOTAL: 1,154,220 1.01%
------------------------------------------------------ --------- ----- ------ ---
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription
right exists:
------------------------------------------------------------
Details, including nature of the rights concerned
and relevant percentages:
------------------------------------------------------------
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of securities Price per unit
security
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 2,025 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 260 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 550 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 9,870 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 6,890 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 2,786 3866.00p
------------------------- ------------- -------------------- --------------
1p Ordinary shares Sale 46 3866.42p
------------------------- ------------- -------------------- --------------
(b) Cash-settled derivative transactions
Class of Product description Nature of dealing Number of Price
relevant e.g. CFD e.g. opening/closing a long/short position, increasing/reducing reference per
security a long/short position securities unit
-------- ------------------- ---------------------------------------------------------------- ---------- -----
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry Option
relevant description purchasing, securities price e.g. American, European etc. date money
security e.g. call selling, to which per paid/
option varying option unit received
etc. relates per
unit
-------- ----------- ----------- ---------- -------- ----------------------------- ------ --------
(ii) Exercise
Class of Product description Exercising/ Number of Exercise
relevant e.g. call option exercised securities price per
security against unit
------------- ------------------- ------------ ------------- -------------
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Price per unit
security e.g. subscription, conversion Details (if applicable)
------------------ ------------------------------- ------- ----------------
1p Ordinary shares Transfer out 480
------------------ ------------------------------- ------- ----------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or
any agreement or understanding, formal or informal,
relating to relevant securities which may be an inducement
to deal or refrain from dealing entered into by the
person making the disclosure and any party to the
offer or any person acting in concert with a party
to the offer:
Irrevocable commitments and letters of intent should
not be included. If there are no such agreements,
arrangements or understandings, state "none"
-----------------------------------------------------------
None
-----------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding,
formal or informal, between the person making the
disclosure and any other person relating to:
(i) the voting rights of any relevant securities under
any option; or
(ii) the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
is referenced:
If there are no such agreements, arrangements or understandings,
state "none"
-----------------------------------------------------------------
None
-----------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? No
---------------------------------------------------
Date of disclosure: 16/01/2024
-------------------- ----------------------------------
Contact name: Joe Brady -- Compliance Department
-------------------- ----------------------------------
Telephone number: 0151 243 2924
-------------------- ----------------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at.
(END) Dow Jones Newswires
January 16, 2024 08:02 ET (13:02 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Nov 2023 to Nov 2024
